| Primary |
| Product Used For Unknown Indication |
40.2% |
| Drug Use For Unknown Indication |
23.8% |
| Pain |
10.2% |
| Back Pain |
5.6% |
| Hypertension |
2.6% |
| Arthralgia |
1.7% |
| Procedural Pain |
1.7% |
| Toothache |
1.7% |
| Sciatica |
1.5% |
| Neck Pain |
1.4% |
| Rheumatoid Arthritis |
1.4% |
| Neuralgia |
1.2% |
| Surgery |
1.2% |
| Depression |
1.0% |
| Osteoarthritis |
0.9% |
| Anxiety |
0.8% |
| Arthritis Bacterial |
0.8% |
| Atrial Fibrillation |
0.8% |
| Polyarthritis |
0.8% |
| Drug Exposure During Pregnancy |
0.7% |
|
| Vomiting |
17.0% |
| Somnolence |
8.9% |
| Urinary Retention |
6.7% |
| Toxic Skin Eruption |
5.9% |
| Vertigo |
5.9% |
| Hypoglycaemia |
5.2% |
| Neutropenia |
5.2% |
| International Normalised Ratio Increased |
4.4% |
| Malaise |
4.4% |
| Intentional Overdose |
3.7% |
| Pancreatitis Acute |
3.7% |
| Suicide Attempt |
3.7% |
| Transaminases Increased |
3.7% |
| Tremor |
3.7% |
| Epilepsy |
3.0% |
| Fall |
3.0% |
| Hepatitis Cholestatic |
3.0% |
| Hepatocellular Injury |
3.0% |
| Hyponatraemia |
3.0% |
| Nausea |
3.0% |
|
| Secondary |
| Drug Use For Unknown Indication |
33.7% |
| Product Used For Unknown Indication |
19.8% |
| Pain |
10.1% |
| Hypertension |
4.2% |
| Back Pain |
3.7% |
| Rheumatoid Arthritis |
3.0% |
| Neck Pain |
2.7% |
| Ankylosing Spondylitis |
2.6% |
| Cholelithiasis |
2.6% |
| Herpes Zoster |
2.4% |
| Cholecystectomy |
2.2% |
| Influenza |
2.2% |
| Ill-defined Disorder |
1.6% |
| Depression |
1.4% |
| Anxiety |
1.3% |
| Arthralgia |
1.3% |
| Constipation |
1.3% |
| Haemorrhoids |
1.3% |
| Toothache |
1.3% |
| Type 2 Diabetes Mellitus |
1.1% |
|
| Somnolence |
13.3% |
| Vomiting |
10.2% |
| Fall |
7.0% |
| Neuropathy Peripheral |
7.0% |
| Neutropenia |
6.3% |
| Tuberculosis |
6.3% |
| Pancreatitis Acute |
4.7% |
| Sense Of Oppression |
4.7% |
| Paraesthesia |
3.9% |
| Pruritus |
3.9% |
| Rash Papular |
3.9% |
| Stevens-johnson Syndrome |
3.9% |
| Toxic Skin Eruption |
3.9% |
| Interstitial Lung Disease |
3.1% |
| Reversible Posterior Leukoencephalopathy Syndrome |
3.1% |
| Rhabdomyolysis |
3.1% |
| Ulcerative Keratitis |
3.1% |
| Urinary Retention |
3.1% |
| Vertigo |
3.1% |
| Hepatitis Cholestatic |
2.3% |
|
| Concomitant |
| Drug Use For Unknown Indication |
23.6% |
| Product Used For Unknown Indication |
16.5% |
| Rheumatoid Arthritis |
10.8% |
| Pain |
10.3% |
| Hypertension |
7.3% |
| Depression |
3.5% |
| Osteoporosis |
3.0% |
| Breast Cancer |
2.8% |
| Ankylosing Spondylitis |
2.6% |
| Crohn's Disease |
2.2% |
| Multiple Myeloma |
2.2% |
| Thrombosis Prophylaxis |
2.2% |
| Headache |
2.0% |
| Abdominal Pain |
1.9% |
| Prophylaxis |
1.8% |
| Type 2 Diabetes Mellitus |
1.8% |
| Psoriatic Arthropathy |
1.5% |
| Anxiety |
1.4% |
| Asthma |
1.4% |
| Back Pain |
1.4% |
|
| Tachycardia |
12.9% |
| Renal Failure Acute |
11.8% |
| Vomiting |
8.2% |
| Thrombocytopenia |
6.5% |
| Urticaria |
5.9% |
| Hyponatraemia |
5.3% |
| Pyrexia |
5.3% |
| Vertigo |
5.3% |
| Weight Decreased |
4.7% |
| Toxic Skin Eruption |
4.1% |
| Malnutrition |
3.5% |
| Pancytopenia |
3.5% |
| Subdural Haematoma |
3.5% |
| Axonal Neuropathy |
2.9% |
| Cytolytic Hepatitis |
2.9% |
| Lung Cancer Metastatic |
2.9% |
| Pulmonary Embolism |
2.9% |
| Urinary Tract Infection |
2.9% |
| Hepatitis |
2.4% |
| Ischaemic Stroke |
2.4% |
|
| Interacting |
| Drug Use For Unknown Indication |
44.1% |
| Atrial Fibrillation |
17.6% |
| Back Pain |
11.8% |
| Product Used For Unknown Indication |
11.8% |
| Arrhythmia |
8.8% |
| Depression |
2.9% |
| Status Epilepticus |
2.9% |
|
| International Normalised Ratio Increased |
28.6% |
| Myoclonus |
14.3% |
| Off Label Use |
14.3% |
| Orthostatic Hypotension |
14.3% |
| Shock Haemorrhagic |
14.3% |
| Transaminases Increased |
14.3% |
|
